176 related articles for article (PubMed ID: 2416441)
1. Tumor markers: value and limitations in the management of cancer patients.
Bates SE; Longo DL
Cancer Treat Rev; 1985 Sep; 12(3):163-207. PubMed ID: 2416441
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
Burg-Kurland CL; Purnell DM; Combs JW; Hillman EA; Harris CC; Trump BF
Cancer Res; 1986 Jun; 46(6):2936-43. PubMed ID: 2421889
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of five tumor markers (AFP, CEA, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumors.
Szymendera JJ; Zborzil J; Sikorowa L; Leńko J; Kamińska JA; Gadek A
Oncology; 1983; 40(1):1-10. PubMed ID: 6185897
[TBL] [Abstract][Full Text] [Related]
4. Tumour markers in urology: aids in cancer diagnosis and management.
Wahren B
Urol Res; 1979 Jun; 7(2):57-67. PubMed ID: 89748
[No Abstract] [Full Text] [Related]
5. Placental proteins as tumor markers.
Braunstein GD
Immunol Ser; 1990; 53():673-701. PubMed ID: 1713070
[TBL] [Abstract][Full Text] [Related]
6. [Tumor markers].
Cappelaere P
Rev Prat; 1988 Jun; 38(17):1058-63. PubMed ID: 2457249
[No Abstract] [Full Text] [Related]
7. Tumor markers in advanced nonseminomatous testicular cancer.
Bosl GJ; Lange PH; Nochomovitz LE; Goldmann A; Fraley EE; Rosai J; Johnson K; Kennedy BJ
Cancer; 1981 Feb; 47(3):572-6. PubMed ID: 6164464
[TBL] [Abstract][Full Text] [Related]
8. [Tumor markers in gynecologic malignancies].
Tojo S; Suzuki A; Fujii S; Ashitaka Y; Maruo T; Matsuura S
Gan No Rinsho; 1983 May; 29(6):678-83. PubMed ID: 6192268
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemistry of germ cell and trophoblastic neoplasms.
Niehans GA; Manivel JC; Copland GT; Scheithauer BW; Wick MR
Cancer; 1988 Sep; 62(6):1113-23. PubMed ID: 2457424
[TBL] [Abstract][Full Text] [Related]
10. The clinical significances of carcinoembryonic proteins in patients with ovarian carcinoma.
Tottori K; Takeuchi S
Nihon Sanka Fujinka Gakkai Zasshi; 1981 Jan; 33(1):142-50. PubMed ID: 6164739
[TBL] [Abstract][Full Text] [Related]
11. Use of serum tumor markers in cancer diagnosis and management.
Bates SE; Longo DL
Semin Oncol; 1987 Jun; 14(2):102-38. PubMed ID: 2438773
[No Abstract] [Full Text] [Related]
12. Tumor-associated antigens in polyps and carcinoma of the human large bowel.
Skinner JM; Whitehead R
Cancer; 1981 Mar; 47(6):1241-5. PubMed ID: 6164469
[TBL] [Abstract][Full Text] [Related]
13. Preneoplasia and neoplasia of the bronchus, esophagus, and colon: the use of markers in determining phenotypes and classification.
Trump BF; McDowell EM; Shamsuddin AK; Phelps PC; Purnell DM; Wilson TS; Banks-Schlegel SP; Kurland CL; Harris CC
Monogr Pathol; 1985; (26):101-39. PubMed ID: 2414648
[No Abstract] [Full Text] [Related]
14. Value of five tumor markers (AFP, CEA, hCG, hPL and SP1) in diagnosis and staging of testicular germ cell tumors.
Szymendera JJ; Zborzil J; Sikorowa L; Kamińska JA; Gadek A
Oncology; 1981; 38(4):222-9. PubMed ID: 6165945
[TBL] [Abstract][Full Text] [Related]
15. [Sense and nonsense of tumor markers in practice].
Joss R; Cerny T
Schweiz Med Wochenschr; 1990 May; 120(19):693-703. PubMed ID: 1693445
[TBL] [Abstract][Full Text] [Related]
16. Serum tumor markers in patients with metastatic germ cell tumors of the testis. A 10-year experience.
Bosl GJ; Geller NL; Cirrincione C; Nisselbaum J; Vugrin D; Whitmore WF; Golbey RB
Am J Med; 1983 Jul; 75(1):29-35. PubMed ID: 6190398
[TBL] [Abstract][Full Text] [Related]
17. [Placental and embryonal proteins as antigens in the immunodiagnosis of malignant tumors].
Tatarinov IuS
Vestn Akad Med Nauk SSSR; 1977; (10):90-3. PubMed ID: 72463
[No Abstract] [Full Text] [Related]
18. Localization of alpha-fetoprotein and human chorionic gonadotropin to specific histologic types of nonseminomatous testicular cancer.
Fowler JE; Sesterhenn I; Stutzman RE; Mostofi FK
Urology; 1983 Dec; 22(6):649-54. PubMed ID: 6196899
[TBL] [Abstract][Full Text] [Related]
19. Serum tumor markers.
Perkins GL; Slater ED; Sanders GK; Prichard JG
Am Fam Physician; 2003 Sep; 68(6):1075-82. PubMed ID: 14524394
[TBL] [Abstract][Full Text] [Related]
20. Biochemical markers in the plasma and tumors of patients with gynecologic malignancies.
van Nagell JR; Donaldson ES; Hanson MB; Gay EC; Pavlik EJ
Cancer; 1981 Jul; 48(2 Suppl):495-503. PubMed ID: 6168368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]